Tag Archives: FDA
The brain tumor community is dedicated to fighting one of the toughest battles imaginable. Thus we are all – from patients, to caregivers, to doctors, to scientists, to advocates – constantly looking forward to the next hurdle we have to jump on our mission toward a cure. Here at the National Brain Tumor Society, specifically, […]
At the end of summer we told you all about a new initiative of the National Brain Tumor Society called the Clinical Trial Endpoints Initiative, which aims to jumpstart brain tumor treatment development. At the time we were just getting back from an extremely fruitful meeting with the U.S. Food & Drug Administration (FDA), which […]
National Brain Tumor Society staff and advisors recently met with the U.S. Food and Drug Administration (FDA) to discuss how various stakeholders in brain tumor drug development could work together to increase the volume and speed of approvals for new treatments for this disease.